BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 25, Issue 11
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (21087)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF2165
WORD375
HTML14077
Figures (1-1)261
Tables (1-3)274
 Sum=17152
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse657
Download752
 Sum=1409
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1092
Download1434
 Sum=2526
Mar 21, 2019 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J Gastroenterol 2019; 25(11): 1307-1326 [PMID: 30918425 DOI: 10.3748/wjg.v25.i11.1307]
URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1307.htm
Number Citing Articles
1
Banrida Wahlang, Savitri Appana, K. Cameron Falkner, Craig J. McClain, Guy Brock, Matthew C. Cave. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004. Environmental Science and Pollution Research 2020; 27(6): 6476 doi: 10.1007/s11356-019-07066-x
2
Sun Kyung Jeon, Jeong Min Lee, Ijin Joo. Clinical Feasibility of Quantitative Ultrasound Imaging for Suspected Hepatic Steatosis: Intra- and Inter-examiner Reliability and Correlation with Controlled Attenuation Parameter. Ultrasound in Medicine & Biology 2021; 47(3): 438 doi: 10.1016/j.ultrasmedbio.2020.11.009
3
Wentao Zhu, Pei Shi, Jiwei Fu, An Liang, Ting Zheng, Xiaoping Wu, Songsong Yuan. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01752-5
4
Mariana Cassiano Alves, Mário Mezêncio De Morais Júnior, Beatriz de Oliveira Ávila, Hiaggo Filmiano Rocha, Elder Francisco Latorraca, Lucélia Rita Gaudino Caputo. A RELAÇÃO DAS CÉLULAS ESTRELADAS NAS PRINCIPAIS ETIOLOGIAS DA CIRROSE HEPÁTICA. Revista Contemporânea 2023; 3(8): 12054 doi: 10.56083/RCV3N8-116
5
Nipun Verma, Ajay Duseja, Manu Mehta, Arka De, Huapeng Lin, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Ruveena Bhavani Rajaram, Wah‐Kheong Chan, Sanjiv Mahadeva, Ming‐Hua Zheng, Wen‐Yue Liu, Sombat Treeprasertsuk, Thaninee Prasoppokakorn, Satoru Kakizaki, Yosuke Seki, Kazunori Kasama, Phunchai Charatcharoenwitthaya, Phalath Sathirawich, Anand Kulkarni, Hery Djagat Purnomo, Lubna Kamani, Yeong Yeh Lee, Mung Seong Wong, Eunice X. X. Tan, Dan Yock Young. Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study. Alimentary Pharmacology & Therapeutics 2024; 59(6): 774 doi: 10.1111/apt.17891
6
Yoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, Kumiko Hosono, Yukiko Suama, Yukie Ohtakaki, Arihito Nauchi, Naoto Yasuda, Soh Mitsuta, Kouichi Miura, Takuma Yamamoto, Tatsunori Hosono, Akihiro Yoshida, Ippei Kawanishi, Hideaki Fukushima, Masao Kinoshita, Atsushi Umeda, Yuichi Kinoshita, Kana Fukami, Toshio Miyawaki, Hideki Fujii, Yuichi Yoshida, Miwa Kawanaka, Hideyuki Hyogo, Asahiro Morishita, Hideki Hayashi, Hiroshi Tobita, Kengo Tomita, Tadashi Ikegami, Hirokazu Takahashi, Masato Yoneda, Dae Won Jun, Yoshio Sumida, Takeshi Okanoue, Atsushi Nakajima. SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum. Journal of Gastroenterology 2023; 58(2): 79 doi: 10.1007/s00535-022-01932-1
7
Wen-Xiu Liu, Lei Liu. Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction. World Journal of Hepatology 2024; 16(7): 990-994 doi: 10.4254/wjh.v16.i7.990
8
Julieta Trinks, María F Mascardi, Adrián Gadano, Sebastián Marciano. Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?. World Journal of Gastroenterology 2024; 30(14): 1982-1989 doi: 10.3748/wjg.v30.i14.1982
9
Guoliang Yin, Hongyi Liang, Wenxiu Sun, Shizhao Zhang, Yanan Feng, Pengpeng Liang, Suwen Chen, Xiangyi Liu, Wenchao Pan, Fengxia Zhang. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1016745
10
Hidekatsu Kuroda, Yudai Fujiwara, Tamami Abe, Tomoaki Nagasawa, Takuma Oguri, Sachiyo Noguchi, Naohisa Kamiyama, Yasuhiro Takikawa, Gianfranco D. Alpini. Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis. PLOS ONE 2021; 16(4): e0249493 doi: 10.1371/journal.pone.0249493
11
Rong Yu, Weijiang Xie, Hewei Peng, Lili Lu, Shuo Yin, Shanghua Xu, Zhijian Hu, Xian-E Peng. Diagnostic value of triglyceride–glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study. BMJ Open 2023; 13(9): e075413 doi: 10.1136/bmjopen-2023-075413
12
Dominika Maciejewska, Arleta Drozd, Karolina Skonieczna-Żydecka, Marta Skórka-Majewicz, Karolina Dec, Karolina Jakubczyk, Anna Pilutin, Ewa Stachowska. Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?. Molecules 2020; 25(9): 2026 doi: 10.3390/molecules25092026
13
Ekram W. Abd El-Wahab, Rehab A. Zein El-Abedin, Walid M. Ahmed, Hanan Z. Shatat. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting. The American Journal of the Medical Sciences 2020; 360(6): 662 doi: 10.1016/j.amjms.2020.06.020
14
Xiong‐Zhang Yin, Wei‐Ming Chi, Ling Zhang, Yan‐Qi Su, Zhong‐Yuan Zhang, Cheng‐Bin Xue. Protective effects of Dendrobium candidum Wall ex Lindl. on high‐fat diet‐induced liver damage in mice . Journal of Food Biochemistry 2021; 45(4) doi: 10.1111/jfbc.13687
15
Ismael Yepes Barreto, Diana Romero Florez, Jorge Coronado Daza. Factores de riesgo para fibrosis hepática en pacientes diabéticos con enfermedad renal cronica terminal. Revista colombiana de Gastroenterología 2023; 38(3): 278 doi: 10.22516/25007440.1061
16
Kengo Moriyama. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Fatty Liver-Related Indices in a Japanese Population. Metabolic Syndrome and Related Disorders 2024; 22(3): 190 doi: 10.1089/met.2023.0212
17
Ivana Mikolasevic, Viktor Domislovic, Irena Krznaric-Zrnic, Zeljko Krznaric, Lucija Virovic-Jukic, Sanja Stojsavljevic, Ivica Grgurevic, Sandra Milic, Ivan Vukoja, Petra Puz, Merica Aralica, Goran Hauser. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy. Medicina 2022; 58(2): 252 doi: 10.3390/medicina58020252
18
Madalina-Gabriela Taru, Lidia Neamti, Vlad Taru, Lucia Maria Procopciuc, Bogdan Procopet, Monica Lupsor-Platon. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep Approach. Diagnostics 2023; 13(4): 788 doi: 10.3390/diagnostics13040788
19
Muhammad Amjad Pervez, Dilshad Ahmed Khan, Atiq Ur Rehman Slehria, Aamir Ijaz. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. Complementary Therapies in Medicine 2020; 52: 102494 doi: 10.1016/j.ctim.2020.102494
20
Song Lu, Maobin Kuang, Jinjing Yue, Chong Hu, Guotai Sheng, Yang Zou. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01712-z
21
Plator Memaj, Zayd Ouzerara, François R. Jornayvaz. Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(14): 11271 doi: 10.3390/ijms241411271
22
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril. Endpoints in NASH Clinical Trials: Are We Blind in One Eye?. Metabolites 2024; 14(1): 40 doi: 10.3390/metabo14010040
23
Xiaomi Du, Natalie DeForest, Amit R. Majithia. Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.777075
24
Ken M. Chin, Mikel Prieto, Chin K. Cheong, Marcello Di Martino, Benedetto Ielpo, Brian K.P. Goh, Ye X. Koh. Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature. HPB 2021; 23(8): 1164 doi: 10.1016/j.hpb.2021.01.009
25
Jinhua Zhang, Kangli Li, Lingling Pan, Fei Teng, Peizhen Zhang, Bingquan Lin, Youwen Yuan, Xueyun Wei, Wenyuan Li, Huijie Zhang. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01721-9
26
Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz. Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gut and Liver 2020; 14(4): 486 doi: 10.5009/gnl19173
27
Yan-Ci Zhao, Guo-Jun Zhao, Ze Chen, Zhi-Gang She, Jingjing Cai, Hongliang Li. Nonalcoholic Fatty Liver Disease. Hypertension 2020; 75(2): 275 doi: 10.1161/HYPERTENSIONAHA.119.13419
28
Yajie Ding, Zongzhe Tang, Minxian Wang, Min Wang, Ru Zhang, Liuxin Zhang, Mengting Zhang, Qing Guan, Jie Wang. Combining serum uric acid and fatty liver index to improve prediction quality of nonalcoholic fatty liver disease. Saudi Journal of Gastroenterology 2023; 29(3): 191 doi: 10.4103/sjg.sjg_484_22
29
Abdulrahman ISMAIEL, Daniel-Corneliu LEUCUTA, Stefan-Lucian POPA, Sharmila FAGOONEE, Rinaldo PELLICANO, Ludovico ABENAVOLI, Dan L. DUMITRASCU. Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysis. Panminerva Medica 2021; 63(4) doi: 10.23736/S0031-0808.20.04171-3
30
Hongli Chen, Yuexing Liu, Dan Liu, Yebei Liang, Zhijun Zhu, Keqing Dong, Huating Li, Yuqian Bao, Jiarui Wu, Xuhong Hou, Weiping Jia, Feng Liu. Sex- and age-specific associations between abdominal fat and non-alcoholic fatty liver disease: a prospective cohort study. Journal of Molecular Cell Biology 2024; 15(11) doi: 10.1093/jmcb/mjad069
31
Sorina I. Stan, Teodora Biciusca, Viorel Biciusca, Ramona Cioboata, Diana Clenciu, Adina Mitrea, Alice Elena Ghenea, Suzana Danoiu. A Current Approach to Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients. Gastroenterology Insights 2023; 14(3): 363 doi: 10.3390/gastroent14030027
32
Guanjun Liu, Dongmei Wu, Yiyang Wen, Shundong Cang. Immune-associated molecular occurrence and prognosis predictor of hepatocellular carcinoma: an integrated analysis of GEO datasets. Bioengineered 2021; 12(1): 5253 doi: 10.1080/21655979.2021.1962147
33
Shuaiyin Zheng, Di Li, Zhuoyue Shi, Ying Yang, Lidan Li, Peidi Chen, Xieerwaniguli A bulimiti, Fuye Li. Development and validation of a nomogram for nonalcoholic fatty liver disease in Western Xinjiang, China. European Journal of Gastroenterology & Hepatology 2024; 36(10): 1220 doi: 10.1097/MEG.0000000000002807
34
Xiaoxiao Chen, Shuzhan Yang, Haiqiong Yu, Xinliang Fu, Wanyan Li, Bingxin Li, Cheng Fu, Xuezhen Cao, Danning Xu, Nan Cao. Identification of key genes involved in the alleviative effects of Polysaccharide of Atractylodes macrocephala Koidz on high-fat diet-induced nonalcoholic fatty liver disease in mice. Journal of Functional Foods 2024; 116: 106201 doi: 10.1016/j.jff.2024.106201
35
Abdulhakeem S. Alamri, Majid Alhomrani, Walaa F. Alsanie, Ahmad Joman Alghamdi, Zaher M. Alghamdi, Abdualmohsen A. Al-Subaie, Yasser A. Alharthi, Hesham H. Alqurashi, Syed Mohammed Basheeruddin Asdaq. Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study. Saudi Journal of Biological Sciences 2021; 28(9): 4921 doi: 10.1016/j.sjbs.2021.05.063
36
Antonio Carlos Soares Pantaleão, Marcio Pinto de Castro, Krishynan Shanty Fernandes Meirelles Araujo, Carlos Frederico Ferreira Campos, André Luiz Alves da Silva, José Eduardo Ferreira Manso, João Carlos Machado. Ultrasound biomicroscopy for the assessment of early-stage nonalcoholic fatty liver disease induced in rats by a high-fat diet. Ultrasonography 2022; 41(4): 750 doi: 10.14366/usg.21182
37
Menglong Li, Wen Shu, Jiawulan Zunong, Nubiya Amaerjiang, Huidi Xiao, Dan Li, Sten H. Vermund, Yifei Hu. Predictors of non-alcoholic fatty liver disease in children. Pediatric Research 2022; 92(1): 322 doi: 10.1038/s41390-021-01754-6
38
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. Journal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
39
Xia Wang, Weiqin Li, Jiangfeng Fu, Yaping Ni, Kaige Liu, Fenglin Liu. Correlation between T-Lymphocyte Subsets, Regulatory T Cells, and Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6250751
40
Yuping Zeng, He He, Zhenmei An, Jin Chai. Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1254014
41
Feng Gao, Jiao‐Feng Huang, Kenneth I. Zheng, Xiao‐Yan Pan, Hong‐Lei Ma, Wen‐Yue Liu, Christopher D. Byrne, Giovanni Targher, Yang‐Yang Li, Yong‐Ping Chen, Wah‐Kheong Chan, Ming‐Hua Zheng. Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2020; 35(10): 1804 doi: 10.1111/jgh.15055
42
Theodoros Androutsakos, Konstantinos Dimitriadis, Konstantinos Revenas, Chrysovalantis Vergadis, Dimitrios-Dorotheos Papadakis, Stratigoula Sakellariou, Christos Vallilas, Gregorios Hatzis. Liver Biopsy: To Do or Not to Do – A Single-Center Study. Digestive Diseases 2023; 41(6): 913 doi: 10.1159/000533328
43
Ying Wang, Zishu Zeng, Lin Guan, Ran Ao. GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non‐alcoholic fatty liver disease via microRNA‐200 and the MAPK pathway. Journal of Cellular and Molecular Medicine 2020; 24(11): 6107 doi: 10.1111/jcmm.15212
44
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
45
Matthew Thomas, Manjiri Dighe, Orpheus Kolokythas, Mladen Zecevic, Ann Wilson, Todd Erpelding, Theodore J. Dubinsky. Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing Degree of Steatosis in NAFLD and Non-NAFLD Patients. Ultrasound Quarterly 2023;  doi: 10.1097/RUQ.0000000000000648
46
Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu, Jian-Jun Li. NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-021-01610-w
47
Hirohito Takeuchi, Katsutoshi Sugimoto, Tatsuya Kakegawa, Yusuke Tomita, Hiroshi Takahashi, Takuya Wada, Masakazu Abe, Yu Yoshimasu, Jun Matsubayashi, Toshitaka Nagao, Takao Itoi. The usefulness of a newly developed full‐core biopsy needle in liver biopsy. Hepatology Research 2023; 53(3): 247 doi: 10.1111/hepr.13856
48
Zhijie Xu, Pengyuan He, Jianzhong Xian, Wuzhu Lu, Jingxian Shu, Wentao Luo, Chongjie Gan, Ruoman Ke, Jinyu Xia, Zongping Han, Mingxing Huang. Association between Nonalcoholic Fatty Liver Disease and Bone Mineral Density in HIV-Infected Patients Receiving Long-term TDF-Based Antiretroviral Therapy. Current HIV Research 2021; 19(1): 40 doi: 10.2174/1570162X18999200917120449
49
Hongkun Xue, Yu Wang, Hongwei Xiang, Qi Song, Guowei Zhang, Jianguo Wang, Shaoqin Ge, Rajeev K Singla. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5440347
50
Jingrui Wang, Zhenzhen Su, Yijin Feng, Ruihan Xi, Jiamin Liu, Peixi Wang. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02072-1
51
Wonsik Jung, Muhammad Asaduddin, Hyeongseop Keum, Youngju Son, Dohyun Yoo, Dohyeon Kim, Seojung Lee, Dong Yun Lee, Jin Roh, Sung‐Hong Park, Sangyong Jon. Longitudinal Magnetic Resonance Imaging with ROS‐Responsive Bilirubin Nanoparticles Enables Monitoring of Nonalcoholic Steatohepatitis Progression to Cirrhosis. Advanced Materials 2024; 36(24) doi: 10.1002/adma.202305830
52
Yaqi Guan, Yilun Xu, Huang Su, Xuecheng Sun, Yanxuan Li, Tingting Wang. Effect of serum vitamin D on metabolic associated fatty liver disease: a large population-based study. Scandinavian Journal of Gastroenterology 2022; 57(7): 862 doi: 10.1080/00365521.2022.2039284
53
FaisalA Alsaif, SaraH Alqahtani, AmaniM Alsadoon, KhalidA Alswat, AymanA Abdo, MazenM Hassanain, AbdulsalamB Alsharabi, GhadeerR Aljuhani, HishamM Alkhalidi, MohammadS Elsharkawy, MaramA Alotaibi, FaisalM Sanai, WaleedK Al-hamoudi. Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease. Saudi Journal of Gastroenterology 2020; 26(4): 204 doi: 10.4103/sjg.SJG_29_20
54
Matthias Ocker. Challenges and opportunities in drug development for nonalcoholic steatohepatitis. European Journal of Pharmacology 2020; 870: 172913 doi: 10.1016/j.ejphar.2020.172913
55
Andrej Hari. Ultrasound Elastography—Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment. Medicina 2021; 57(6): 516 doi: 10.3390/medicina57060516
56
Weijian Hang, Hongyang Shu, Zheng Wen, Jinyan Liu, Zhiyuan Jin, Zeqi Shi, Chen Chen, Dao Wen Wang. N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.636204
57
Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Marlyn J. Mayo, Daniel S. Pratt, Raj Vuppalanchi, Zobair M. Younossi. Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis. American Journal of Gastroenterology 2023; 118(2): 232 doi: 10.14309/ajg.0000000000002070
58
Segundo Moran. Prevalence of non alcoholic fatty liver disease and associated factors?. Annals of Hepatology 2022; 27(2): 100659 doi: 10.1016/j.aohep.2022.100659
59
Yanli Zou, Ting Zhan, Jiaxi Liu, Jie Tan, Weijie Liu, Shasha Huang, Yisan cai, Ming Huang, Xiaodong Huang, Xia Tian. CXCL6 promotes the progression of NAFLD through regulation of PPARα. Cytokine 2024; 174: 156459 doi: 10.1016/j.cyto.2023.156459
60
Ruixiang Hu, Bing Wu, Cunchuan Wang, Zilong Wu, Xu Zhang, Xinxin Chen, Guanhua Lu, Kaisheng Yuan. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population. International Journal of Surgery 2024; 110(4): 2044 doi: 10.1097/JS9.0000000000001078
61
Akhila Sai Sree Cherukuri, Poulami Samaddar, Alejos Aguero Carlos, Keerthy Gopalakrishnan, Sunil Gaddam, Lucia T. Valenzuela Perez, Hyun Se Kim Lee, Shuvashis Dey, Sayan Roy, Dipankar Mitra, Petra Hirsova, Shivaram P. Arunachalam. On the Diagnosis of Nonalcoholic Steatohepatitis Using Dielectric Properties: Feasibility in Mouse Model. 2023 IEEE International Conference on Electro Information Technology (eIT) 2023; : 649 doi: 10.1109/eIT57321.2023.10187375
62
Jinying Xia, Guang Jin, Qifeng Hua, Shihan Cui, Jianhui Li. Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.917304
63
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
64
Stanislav Veselskyi, Andrii Pototskyi, Viktor Tomchuk, Viktoriia Gryshchenko, Yevdokiia Reshetnik. Phospholipid composition of bile and blood in rats under correction of experimental fatty hepatosis. Ukrainian journal of veterinary sciences 2023; 14(3): 25 doi: 10.31548/veterinary3.2023.25
65
Grit Andersen, Leona Plum-Mörschel, Paul D. Hockings, Anni Morsing, Mads S. Palle, Olivia Svolgaard, Anne Flint. Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data. Advances in Therapy 2020; 37(12): 4866 doi: 10.1007/s12325-020-01503-x
66
A. Fabrizzio Bardales Silva. Enfermedad hepática grasa relacionada a trastornos metabólicos. Revista Médica Basadrina 2022; 15(4): 85 doi: 10.33326/26176068.2021.4.1259
67
György Jermendy, Márton Kolossváry, Ibolya Dudás, Ádám L. Jermendy, Alexisz Panajotu, Imre F. Suhai, Zsófia D. Drobni, Júlia Karády, Ádám D. Tárnoki, Dávid L. Tárnoki, Szilard Voros, Béla Merkely, Pál Maurovich-Horvat. Effect of genetic and environmental influences on hepatic steatosis: A classical twin study based on computed tomography. Imaging 2020; 12(1): 15 doi: 10.1556/1647.2020.00006
68
Azin Momeni, Maryam Yazdi, Mohammad Esmail Motlagh, Mostafa Qorbani, Roya Kelishadi. Glucose and lipid-related indicators in relation to elevated alanine aminotransferase in a pediatric population. Journal of Pediatric Endocrinology and Metabolism 2024; 37(7): 597 doi: 10.1515/jpem-2024-0092
69
Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block. NAFLD in type 1 diabetes: overrated or underappreciated?. Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/20420188211055557
70
Xiaonan Liu, Shuhong Chen, Lanju Zhang. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. American Journal of Physiology-Endocrinology and Metabolism 2020; 319(1): E34 doi: 10.1152/ajpendo.00528.2019
71
Arash Akhavan Rezayat, Mohammad Ghasemi Nour, Yones Bondarsahebi, Seyyed Amin Hozhabrossadati, Fatemeh Amirkhanlou, Shima Akhavan Rezayat, Mohammadali Kiani, Bahareh Imani. The effects of melatonin therapy on the treatment of patients with Non-alcoholic steatohepatitis: A systematic review and Meta-analysis on clinical trial studies. European Journal of Pharmacology 2021; 905: 174154 doi: 10.1016/j.ejphar.2021.174154
72
Lina Gruneau, Stergios Kechagias, Per Sandström, Mattias Ekstedt, Martin Henriksson. Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease. Hepatology Communications 2023; 7(7) doi: 10.1097/HC9.0000000000000191
73
Jiajun Qiu, Xin Huang, Maobin Kuang, Ruijuan Yang, Jiachong Li, Guotai Sheng, Yang Zou. Lipoprotein Combine Index as a Better Marker for NAFLD Identification Than Traditional Lipid Parameters. Diabetes, Metabolic Syndrome and Obesity 2024; : 2583 doi: 10.2147/DMSO.S462181
74
Laura Sol Grinshpan, Sigal Eilat-Adar, Dana Ivancovsky-Wajcman, Revital Kariv, Michal Gillon-Keren, Shira Zelber-Sagi. Ultra-processed food consumption and non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance: A systematic review. JHEP Reports 2024; 6(1): 100964 doi: 10.1016/j.jhepr.2023.100964
75
Xize Wu, Changbin Yuan, Jiaxiang Pan, Yi Zhou, Xue Pan, Jian Kang, Lihong Ren, Lihong Gong, Yue Li. CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66287-4
76
Lei Zhang, Zhi-Gang She, Hongliang Li, Xiao-Jing Zhang. Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis. Clinical Science 2020; 134(13): 1775 doi: 10.1042/CS20200446
77
Fariba Ahmadizar, Zobair M. Younossi. Exploring Biomarkers in Nonalcoholic Fatty Liver Disease Among Individuals With Type 2 Diabetes Mellitus. Journal of Clinical Gastroenterology 2024;  doi: 10.1097/MCG.0000000000002079
78
Mariana Elorz, Alberto Benito-Boilos, Bertha Araceli Marin, Nuria Pérez Díaz del Campo, Jose Ignacio Herrero, Jose Ignacio Monreal, Josep A. Tur, J. Alfredo Martínez, Maria Angeles Zulet, Itziar Abete. Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study. Nutrients 2022; 14(23): 5160 doi: 10.3390/nu14235160
79
Gregorio Recaredo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, José Ignacio Herrero, Alberto Benito-Boillos, Mariana Elorz, Josep A. Tur, J. Alfredo Martínez, M. Angeles Zulet, Itziar Abete. Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study. Nutrients 2019; 11(10): 2359 doi: 10.3390/nu11102359
80
Weiyi Qu, Tengfei Ma, Jingjing Cai, Xiaojing Zhang, Peng Zhang, Zhigang She, Feng Wan, Hongliang Li. Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.761538
81
Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review. Hepatology Research 2020; 50(6): 645 doi: 10.1111/hepr.13502
82
Suosu Wei, Yanrong Hao, Xiaofeng Dong, Junzhang Huang, Kai Huang, Yujie Xie, Hongjun Liu, Chunyu Wei, Jinan Xu, Wei Huang, Lingguang Dong, Jianrong Yang. The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.985858
83
Shaopeng Li, Peng Wang, Jun Qiu, Yiju Xie, Dawei Yin, Kexue Deng. Comparison of IDEAL-IQ and IVIM-DWI for Differentiating between Alpha Fetoprotein-Negative Hepatocellular Carcinoma and Focal Nodular Hyperplasia. Oncologie 2022; 24(3): 527 doi: 10.32604/oncologie.2022.022815
84
Haofei Hu, Yong Han, Changchun Cao, Yongcheng He. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03611-4
85
Michael Tseng, Taseen Syed, Mohammad Siddiqui. Hepatology. 2025; : 111 doi: 10.1016/B978-0-443-26710-9.00004-3
86
Jie Zhang, Jie Tan, Mengke Wang, Yifen Wang, Mengzhen Dong, Xuefeng Ma, Baokai Sun, Shousheng Liu, Zhenzhen Zhao, Lizhen Chen, Kai Liu, Yongning Xin, Likun Zhuang. Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD. Science Advances 2021; 7(45) doi: 10.1126/sciadv.abh1541
87
Hassan M. Heshmati. Advances in Hepatology. 2021;  doi: 10.5772/intechopen.97568
88
Joanna Goralska, Urszula Razny, Anna Gruca, Anna Zdzienicka, Agnieszka Micek, Aldona Dembinska-Kiec, Bogdan Solnica, Malgorzata Malczewska-Malec. Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity. Biomolecules 2023; 13(4): 675 doi: 10.3390/biom13040675
89
Juma Alkaabi, Bachar Afandi, Omar Alhaj, Darakhshan Kanwal, Adnan Agha. Identifying metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus using clinic-based prediction tools. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1425145
90
Evelyn Nunes Goulart da Silva Pereira, Daniela Polessa Paula, Beatriz Peres de Araujo, Maria de Jesus Mendes da Fonseca, Maria de Fátima Haueisen Sander Diniz, Anissa Daliry, Rosane Harter Griep. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World Journal of Gastroenterology 2021; 27(29): 4913-4928 doi: 10.3748/wjg.v27.i29.4913
91
Maria Duarte, Phyllis Tien, Yifei Ma, Susan M. Noworolski, Natalie Korn, Jennifer C. Price. Controlled attenuation parameter accurately detects liver steatosis in people with HIV. AIDS 2022; 36(15): 2147 doi: 10.1097/QAD.0000000000003351
92
Aunchalee Jaroenlapnopparat, Christopher C. Thompson, Pichamol Jirapinyo. Effect of Transoral Outlet Reduction on Hepatic Fibrosis in Roux-en-Y Gastric Bypass Patients with Weight Regain and Non-alcoholic Fatty Liver Disease. Obesity Surgery 2023; 33(8): 2303 doi: 10.1007/s11695-023-06668-2
93
Guo-heng Zhang, Tian-hao Yuan, Zhen-sheng Yue, Lin Wang, Guo-Rui Dou. The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1019899
94
D. A. Miles, C. S. Levi, J. Uhanova, S. Cuvelier, K. Hawkins, G. Y. Minuk. Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver. Digestive Diseases and Sciences 2020; 65(1): 82 doi: 10.1007/s10620-019-05752-x
95
D. V. Voronov, M. G. Minina, A. K. Chomaev, I. M. Iljinsky, O. M. Tsirulnikova. Liver steatosis in brain death donors. Russian Journal of Transplantology and Artificial Organs 2021; 23(1): 8 doi: 10.15825/1995-1191-2021-1-8-14
96
A-Ra Cho, Yu-Jin Kwon, Jun-Hyuk Lee. Oxidative balance score is inversely associated with the incidence of non-alcoholic fatty liver disease. Clinical Nutrition 2023; 42(8): 1292 doi: 10.1016/j.clnu.2023.06.015
97
Yuting Guo, Juan Chen, Nan Liu, Zheng Liu, Bimin Shi, Hong Sun. Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 225 doi: 10.2147/DMSO.S349153
98
Rebeka Anna Makó, Anna Egresi, Anna Blázovics, Réka Oszlányi, Krisztina Hagymási. Az ómega-3 zsírsavak jelentősége a nem alkoholos zsírmájbetegség kezelésében. Orvosi Hetilap 2023; 164(33): 1294 doi: 10.1556/650.2023.32834
99
Ru Zhang, Minxian Wang, Min Wang, Liuxin Zhang, Yajie Ding, Zongzhe Tang, Zuqiang Fu, Haozhi Fan, Wei Zhang, Jie Wang. Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.648844
100
Chao Wang, Xin Huang, Shiming He, Maobin Kuang, Guobo Xie, Guotai Sheng, Yang Zou. The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02299-3
101
Dae Ho Lee. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism 2020; 35(2): 243 doi: 10.3803/EnM.2020.35.2.243
102
Vanessa Bullón-Vela, Itziar Abete, Josep A. Tur, Jadwiga Konieczna, Dora Romaguera, Xavier Pintó, Emili Corbella, Miguel A. Martínez-González, Carmen Sayón-Orea, Estefanía Toledo, Dolores Corella, Manuel Macías-Gonzalez, Francisco J. Tinahones, Montserrat Fitó, Ramon Estruch, Emilio Ros, Jordi Salas-Salvadó, Lidia Daimiel, Catalina M. Mascaró, Maria Angeles Zulet, José Alfredo Martínez. Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications. Therapeutic Advances in Endocrinology and Metabolism 2020; 11 doi: 10.1177/2042018820958298
103
Jiahui Li, Sudhakar Kundapur Venkatesh, Meng Yin. Advances in Magnetic Resonance Elastography of Liver. Magnetic Resonance Imaging Clinics of North America 2020; 28(3): 331 doi: 10.1016/j.mric.2020.03.001
104
Hideki Hayashi, Yoshihiro Kamada, Hideki Fujii, Hirokazu Takahashi, Satoshi Oeda, Michihiro Iwaki, Takumi Kawaguchi, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue. Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2023; 49(7): 1658 doi: 10.1016/j.ultrasmedbio.2023.03.023
105
Anne Sophie Schou, Jonas Ellegaard Nielsen, Anders Askeland, Malene Møller Jørgensen. . Advances in Clinical Chemistry 2020; 99: 1 doi: 10.1016/bs.acc.2020.02.011
106
Chowdhury F Zaman, Jakia Sultana, Proma Dey, Jui Dutta, Sadia Mustarin, Nuzhat Tamanna, Aditi Roy, Nisha Bhowmick, Mousumi Khanam, Sadia Sultana, Selia Chowdhury, Farjana Khanam, Md Sakibuzzaman, Priyata Dutta. A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022;  doi: 10.7759/cureus.29657
107
Nina Bastati, Matthias Perkonigg, Daniel Sobotka, Sarah Poetter-Lang, Romana Fragner, Andrea Beer, Alina Messner, Martin Watzenboeck, Svitlana Pochepnia, Jakob Kittinger, Alexander Herold, Antonia Kristic, Jacqueline C. Hodge, Stefan Traussnig, Michael Trauner, Ahmed Ba-Ssalamah, Georg Langs. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study. European Radiology 2023; 33(11): 7729 doi: 10.1007/s00330-023-09735-5
108
Nimish Thakral, Hailemichael Desalegn, Luis Antonio Diaz, Daniel Cabrera, Rohit Loomba, Marco Arrese, Juan Pablo Arab. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD. Seminars in Liver Disease 2024; 44(03): 273 doi: 10.1055/a-2364-2928
109
Man Gong, Chengfu Su, Mengzhe Fan, Ping Wang, Bingdi Cui, Zhongyuan Guo, Shaojia Liang, Lianhe Yang, Xiaoqian Liu, Liping Dai, Zhimin Wang. Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology. Journal of Ethnopharmacology 2022; 282: 114603 doi: 10.1016/j.jep.2021.114603
110
Celide Campoverde Cueva, Williams Celedonio-Campos, Brayan Campos-Salazar, Rommel Zambrano-Huailla, Alejandra Zevallos, Jorge Garavito-Renteria. Baveno VII Criteria for the Exclusion of Esophageal Varices in a Peruvian Population: Cross-Sectional Study. Revista colombiana de Gastroenterología 2024; 39(2): 158 doi: 10.22516/25007440.1156
111
Meryem KEÇELİ BAŞARAN, Okan GÜRKAN. Analysis of clinical findings and serum micronutrients in pediatric patients with nonalcoholic fatty liver disease. Journal of Health Sciences and Medicine 2023; 6(1): 35 doi: 10.32322/jhsm.1190206
112
Sonika Verma, Manish Verma, Sunny Khari. Association of Hematological Parameters (Mean Platelet Volume and Red Cell Distribution Width) with Nonalcoholic Fatty Liver Disease. APIK Journal of Internal Medicine 2023; 11(1): 37 doi: 10.4103/ajim.ajim_11_22
113
Zixuan Zhang, James L. Thorne, J. Bernadette Moore. Vitamin D and nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition & Metabolic Care 2019; 22(6): 449 doi: 10.1097/MCO.0000000000000605
114
Tina Linder, Daniel Eppel, Grammata Kotzaeridi, Ingo Rosicky, Gülen Yerlikaya-Schatten, Herbert Kiss, Karen Weißhaupt, Wolfgang Henrich, Latife Bozkurt, Andrea Tura, Michael Roden, Christian S. Göbl. Fatty liver indices and their association with glucose metabolism in pregnancy – An observational cohort study. Diabetes Research and Clinical Practice 2022; 189: 109942 doi: 10.1016/j.diabres.2022.109942
115
Ana Luz Tobaruela-Resola, José I. Riezu-Boj, Fermin I. Milagro, Paola Mogna-Pelaez, José I. Herrero, Mariana Elorz, Alberto Benito-Boillos, Josep A. Tur, J. Alfredo Martínez, Itziar Abete, M. Angeles Zulet. Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention. Nutrients 2024; 16(11): 1547 doi: 10.3390/nu16111547
116
Samantha Maurotti, Roberta Pujia, Elisa Mazza, Maria Francesca Pileggi, Franco Arturi, Maria Grazia Tarsitano, Tiziana Montalcini, Arturo Pujia, Yvelise Ferro. Low Relative Handgrip Strength Is Associated with a High Risk of Non-Alcoholic Fatty Liver Disease in Italian Adults: A Retrospective Cohort Study. Applied Sciences 2023; 13(22): 12489 doi: 10.3390/app132212489
117
David T. Fetzer, Ivan M. Rosado-Mendez, Michael Wang, Michelle L. Robbin, Arinc Ozturk, Keith A. Wear, Juvenal Ormachea, Timothy A. Stiles, J. Brian Fowlkes, Timothy J. Hall, Anthony E. Samir. Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization. Radiology 2022; 305(2): 265 doi: 10.1148/radiol.212808
118
Bou-Zenn Lin, Tsung-Jung Lin, Chih-Lin Lin, Li-Ying Liao, Ting-An Chang, Buo-Jia Lu, Kuan-Yang Chen. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. Journal of the Chinese Medical Association 2021; 84(6): 606 doi: 10.1097/JCMA.0000000000000530
119
Sahar Yarahmadi, Navid Farahmandian, Reza Fadaei, Mehdi Koushki, Elham Bahreini, Saeed Karima, Sepideh Barzin Tond, Azadeh Rezaei, Mitra Nourbakhsh, Soudabeh Fallah. Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33. DNA and Cell Biology 2023; 42(2): 82 doi: 10.1089/dna.2022.0581
120
Hai-Jian Sun, Zhi-Yuan Wu, Xiao-Wei Nie, Xin-Yu Wang, Jin-Song Bian. Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential. Journal of Advanced Research 2021; 27: 127 doi: 10.1016/j.jare.2020.05.010
121
Rong-Hong Hsieh, Yu-Ju Chien, Wen-Yi Lan, Yung-Kai Lin, Yung-Hsiang Lin, Chi-Fu Chiang, Ming-Ta Yang. Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial. Current Developments in Nutrition 2024; 8(3): 102083 doi: 10.1016/j.cdnut.2024.102083
122
Marton Fekete, Marton Piroska, Marcell Szily, Mercedesz Erdei, Zsofia Jokkel, Helga Szabo, Levente Littvay, Gyorgy Baffy, Adam Domonkos Tarnoki, David Laszlo Tarnoki. Heritability analysis of liver stiffness detected by ultrasound shear wave elastography: a twin study. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e766 doi: 10.1097/MEG.0000000000002246
123
Jakub Morze, Manja Koch, Sarah A. Aroner, Matthew Budoff, Robyn L. McClelland, Kenneth J. Mukamal, Majken K. Jensen. Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of Atherosclerosis. Journal of Clinical Medicine 2020; 9(11): 3522 doi: 10.3390/jcm9113522
124
Yang Ma, Jinguo Wang, Wenping Xiao, Xiaoming Fan. A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1410668
125
S. Marciano, M. Dirchwolf, M.C. Torres, J. Allevato, C. García Dans, B. García, F. Pollarsky, L. Gaite, E. Sirotinsky, B. Rios, M.N. Anselmo, M. Peche, E. Hurtado, L. Haddad, A. Narvaez, E. Mauro, A. Martinez, C. Bellizzi, N. Ratusnu, C. D́Amico, S. Arora, A. Gadano. Evaluación de fibrosis en pacientes con enfermedad por hígado graso no alcohólico: adherencia a los algoritmos propuestos y barreras para cumplir con ellos. Revista de Gastroenterología de México 2022; 87(1): 4 doi: 10.1016/j.rgmx.2020.08.006
126
Zobair M. Younossi, Mazen Noureddin, David Bernstein, Paul Kwo, Mark Russo, Mitchell L. Shiffman, Ziad Younes, Manal Abdelmalek. Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations. American Journal of Gastroenterology 2021; 116(2): 254 doi: 10.14309/ajg.0000000000001054
127
Maryam Dorostghol, Mohammad M. Gharibvand, Mohammad G. Hanafi, Azim Motamedfar. Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls. Journal of Family Medicine and Primary Care 2024; 13(2): 425 doi: 10.4103/jfmpc.jfmpc_94_23
128
Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Maria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD. Current Obesity Reports 2024; 13(3): 510 doi: 10.1007/s13679-024-00574-z
129
Stergios Kechagias, Mattias Ekstedt, Christian Simonsson, Patrik Nasr. Non-invasive diagnosis and staging of non-alcoholic fatty liver disease. Hormones 2022; 21(3): 349 doi: 10.1007/s42000-022-00377-8
130
Madalina-Gabriela Taru, Monica Lupsor-Platon. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography. Cancers 2023; 15(16): 4097 doi: 10.3390/cancers15164097
131
Mazen Noureddin, Fady Ntanios, Deepa Malhotra, Katherine Hoover, Birol Emir, Euan McLeod, Naim Alkhouri. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning. Hepatology Communications 2022; 6(7): 1537 doi: 10.1002/hep4.1935
132
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. European Journal of Nutrition 2021; 60(6): 3043 doi: 10.1007/s00394-020-02476-x
133
Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. International Journal of Molecular Sciences 2021; 22(21): 11905 doi: 10.3390/ijms222111905
134
Yuting Ma, Chengxia Kan, Hongyan Qiu, Yongping Liu, Ningning Hou, Fang Han, Junfeng Shi, Xiaodong Sun. Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.793586
135
Luca Lusnig, Asel Sagingalieva, Mikhail Surmach, Tatjana Protasevich, Ovidiu Michiu, Joseph McLoughlin, Christopher Mansell, Graziano de’ Petris, Deborah Bonazza, Fabrizio Zanconati, Alexey Melnikov, Fabio Cavalli. Hybrid Quantum Image Classification and Federated Learning for Hepatic Steatosis Diagnosis. Diagnostics 2024; 14(5): 558 doi: 10.3390/diagnostics14050558
136
Mubashra Khalid, Zoraiz Munir Khan, Ahmad Sheraz Kahloon. Letter to the Editor: NAFLD improves risk prediction of type 2 diabetes—With effect modification by sex and menopausal status. Hepatology 2024; 79(2): E18 doi: 10.1097/HEP.0000000000000603
137
Antonella Mosca, Nadia Panera, Annalisa Crudele, Anna Alisi. Noninvasive diagnostic tools for pediatric NAFLD: where are we now?. Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1035 doi: 10.1080/17474124.2020.1801413
138
Solène Marie, David K.K. Tripp, Nathan J. Cherrington. Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations. Drug Metabolism and Disposition 2022; 50(4): 492 doi: 10.1124/dmd.121.000413
139
Nikoletta Maria Tagkou, Nicolas Goossens. Stéatose hépatique non alcoolique : diagnostic et traitement en 2022. Schweizer Gastroenterologie 2023; 4(1): 27 doi: 10.1007/s43472-023-00091-9
140
Ze Chen, Ruifeng Tian, Zhigang She, Jingjing Cai, Hongliang Li. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radical Biology and Medicine 2020; 152: 116 doi: 10.1016/j.freeradbiomed.2020.02.025
141
Dragoș Constantin Cucoranu, Marian Pop, Raluca Niculescu, Vlad Vunvulea, Irina-Bianca Kosovski, Radu-Ovidiu Togănel, Eliza Russu, Adrian Vasile Mureșan, Răzvan-Andrei Licu, Anca Bacârea. Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease. Medicina 2023; 59(3): 500 doi: 10.3390/medicina59030500
142
Hao CHEN, Yang ZHOU, Haiping HAO, Jing XIONG. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies. Chinese Journal of Natural Medicines 2024; 22(8): 724 doi: 10.1016/S1875-5364(24)60690-4
143
Guotai Sheng, Song Lu, Qiyang Xie, Nan Peng, Maobin Kuang, Yang Zou. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01561-2
144
Chien-Chih Chen, Wei-Chien Hsu, Han-Ming Wu, Jiun-Yi Wang, Pei-Yu Yang, I-Ching Lin. Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification. Medicina 2021; 57(8): 807 doi: 10.3390/medicina57080807
145
Yen-Ying Chen, Matthew M. Yeh. Non-alcoholic fatty liver disease: A review with clinical and pathological correlation. Journal of the Formosan Medical Association 2021; 120(1): 68 doi: 10.1016/j.jfma.2020.07.006
146
S. Marciano, M. Dirchwolf, M.C. Torres, J. Allevato, C. García Dans, B. García, F. Pollarsky, L. Gaite, E. Sirotinsky, B. Rios, M.N. Anselmo, M. Peche, E. Hurtado, L. Haddad, A. Narvaez, E. Mauro, A. Martinez, C. Bellizzi, N. Ratusnu, C. D’Amico, S. Arora, A. Gadano. Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them. Revista de Gastroenterología de México (English Edition) 2022; 87(1): 4 doi: 10.1016/j.rgmxen.2021.09.002
147
Peng Huang, Biao Tu, Hui-jun Liao, Fei-zhou Huang, Zhen-zhou Li, Kuang-ye Zhu, Feng Dai, Huai-zheng Liu, Tian-yi Zhang, Chuan-zheng Sun. Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85421-0
148
Jinmei Yao, Ying Zhao. Lp-PLA2 silencing ameliorates inflammation and autophagy in nonalcoholic steatohepatitis through inhibiting the JAK2/STAT3 pathway. PeerJ 2023; 11: e15639 doi: 10.7717/peerj.15639
149
Zhi Xin Tan, Bryan Mehta, Kieran Kusel, James Seow, Marilyn Zelesco, Steven Abbott, Rebecca Simons, Glenn Boardman, Christopher J. Welman, Oyekoya T. Ayonrinde. Hepatic steatosis: Qualitative and quantitative sonographic assessment in comparison to histology. Australasian Journal of Ultrasound in Medicine 2024; 27(3): 179 doi: 10.1002/ajum.12381
150
V. V. Gorban, E. V. Matveeva, E. V. Gorban, E. S. Kameneva. The possibilities of transabdominal sonographic diagnosis of liver and intestinal lesions in comorbid gastroesophageal reflux disease. Meditsinskiy sovet = Medical Council 2022; (15): 134 doi: 10.21518/2079-701X-2022-16-15-134-143
151
Renzo Pajuelo-Vasquez, Jerry K. Benites-Meza, Hilda V. Durango-Chavez, Gustavo Salinas-Sedo, Carlos J. Toro-Huamanchumo. Diagnostic performance of the GGT/HDL-C ratio for NAFLD in adults with obesity undergoing bariatric surgery. Diabetes Research and Clinical Practice 2024; 211: 111649 doi: 10.1016/j.diabres.2024.111649
152
Salem Alsaqal, Paul Hockings, Håkan Ahlström, Anders Gummesson, Anders Hedström, Johannes Hulthe, Lars Johansson, Heiko G. Niessen, Corinna Schoelch, Christian Schultheis, Johan Vessby, Alkwin Wanders, Fredrik Rorsman, Charlotte Ebeling Barbier. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis. Journal of Magnetic Resonance Imaging 2022; 56(2): 368 doi: 10.1002/jmri.28040
153
Qichen Long, Fengming Luo, Binghui Li, Ziyang Li, Zhe Guo, Zhiyang Chen, Weimin Wu, Min Hu. Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease. Hepatology Communications 2024; 8(3) doi: 10.1097/HC9.0000000000000310
154
Muharrem Bayrak. Non-invasive diagnosis of nonalcoholic fatty liver disease: impact of age and other risk factors. The Aging Male 2020; 23(5): 1275 doi: 10.1080/13685538.2020.1763293
155
Yuping Zeng, Xia Wang, He He, Lidan Yang, Shuangqin Li, Zhenmei An. Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease. SSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3915431
156
Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World Journal of Hepatology 2023; 15(6): 786-796 doi: 10.4254/wjh.v15.i6.786
157
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher. NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. International Journal of Molecular Sciences 2019; 20(11): 2841 doi: 10.3390/ijms20112841
158
Minbo Zhang, Yu Zhang, Xiaoxiao Jiao, Linying Lai, Yiting Qian, Bo Sun, Wenzhuo Yang. Identification and validation of immune related core transcription factors GTF2I in NAFLD. PeerJ 2022; 10: e13735 doi: 10.7717/peerj.13735
159
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu, Gabriela Ștefănescu. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. Metabolites 2023; 13(11): 1115 doi: 10.3390/metabo13111115
160
Yuraima De Andrade, Saturnino Fernández Bermúdez, Amador Guzman, Jenny Romero, Robert León. Elastografía transitoria 1D (iLivTouch®): experiencia inicial en centro de referencia de hepatología de la ciudad de Caracas (Venezuela). Revista GEN 2024; 78(1): 26 doi: 10.61155/2024.78.1.006
161
Eda Kaya, Yusuf Yilmaz. Obesity and Diabetes. 2020; : 321 doi: 10.1007/978-3-030-53370-0_24
162
Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers. Metabolites 2022; 12(11): 1073 doi: 10.3390/metabo12111073
163
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography. Cancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345